SEC ownership of Alvotech

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001898416.

Comparable stake leader

Aztiq Pharma Partners S.a r.l.

Disclosed value leader

Aztiq Pharma Partners S.a r.l.

Comparable rows

2/50

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
2 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Aztiq Pharma Partners S.a r.l.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001898416
Issuer location
Luxembourg, Luxembourg

Ownership snapshot

Top shareholders of Alvotech (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Aztiq Pharma Partners S.a...
Disclosed value leader
Aztiq Pharma Partners S.a...
Comparable rows
2/50
Latest evidence
30 Jun 2026
13D/G 13F Lead comparable stake: 33% 48 rows are not safely comparable across share classes. 13D/G row: Aztiq Pharma Partners S.a r.l. Showing 1-8 of 50 holder rows.

Quick read

Aztiq Pharma Partners S.a r.l. leads the comparable SEC ownership view at 33%.

2 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Aztiq Pharma Partners S.a r.l.'s linked filing trail.
Comparable ownership Top 2
Aztiq Pharma Partners S.a r.l. 33%
Celtic Holdings SCA 28%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Aztiq Pharma Partners S.a r.l.
13D/G
33%
Reported 13D/G · 17 Dec 2025
$533,786,019
103,849,420 shares
$0 17 Dec 2025
Celtic Holdings SCA
13D/G
Celtic Holdings S.C.A.
28%
Reported 13D/G · 26 Jun 2026
$367,482,379
107,450,988 shares
$0 26 Jun 2026
Rubric Capital Management LP
13F
Company
13F
—
denominator unverified
$57,848,473
15,677,093 shares
— 30 Jun 2026
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$15,732,846
4,263,644 shares
— 30 Jun 2026
Bracebridge Capital, LLC
13F
Company
13F
—
denominator unverified
$14,902,571
4,038,637 shares
— 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$13,965,181
3,689,612 shares
— 30 Jun 2026
FARALLON CAPITAL MANAGEMENT, L.L.C.
13F
Company
13F
—
denominator unverified
$10,552,201
2,859,675 shares
— 30 Jun 2026
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$6,376,328
1,728,002 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 24 Oct 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for Alvotech

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .